Kinks in access to the new COVID-19 vaccine are nationwide. Rural areas will likely feel the brunt.
Some people are finding pharmacies still don't have supply of the shots, and others are having insurance coverage troubles. Here's what's going on.
Lower-income countries did not get the COVID vaccines they needed. So the World Bank and other partners tapped a South African company to cook up the (undisclosed) recipe for the Moderna mRNA vaccine.
Preliminary laboratory studies find antibodies from previous infections and vaccinations can neutralize the BA.2.86 variant. The findings bode well for new boosters on the way this fall.
A panel of advisers to the Food and Drug Administration has recommended revising the current COVID-19 vaccine so that it specifically targets omicron.
Now that official COVID emergency declarations have ended, how should people evaluate their risk of SARS-CoV-2? That's the subject of our frequently asked questions offering.
Once U.S. stockpiles of COVID-19 vaccine run out, Moderna says it might charge as much as $130 per dose, but give people who lack health insurance a break. Critics say that's not enough help.
Insurers, employers, taxpayers and other consumers will all be affected as drugmakers move these products to the commercial market in May. How much you'll pay depends on your health insurance.
The new approach would simplify vaccination guidance so that, every fall, people would get a new shot, updated to try to match whatever variant is dominant.
The decision aims to better protect the littlest kids amid an uptick in COVID-19 cases around the country. The Centers for Disease Control and Prevention is expected to sign off soon.
Two reasons for the renewed COVID-19 vaccine campaign include updated booster shots and the approach of fall and winter.
The inventors of Corbevax said it was cheap, easy to make, effective and safe. They hoped it could bring vaccine equity to countries that can't access costlier shots. Has it lived up to its promise?
A coalition of religious groups, conservative think tanks, and Republican attorneys general have chipped away at local and state authority, altering how the nation can respond during health crises.
The Food and Drug Administration will have to decide the exact recipe, but a combination shot is expected that adds protection against a version of the omicron variant to the original vaccine.